168
Views
32
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: The first 100 patients treated in Scandinavia

, , , , , , , , , , , & show all
Pages 221-227 | Received 12 Oct 2005, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maurizio Vecchi, Piero Vernia, Gabriele Riegler, Renata D’Incà, Vito Annese & Siro Bagnoli. (2013) Therapeutic landscape for ulcerative colitis: where is the Adacolumn® system and where should it be?. Clinical and Experimental Gastroenterology 6, pages 1-7.
Read now
Giampaolo Bresci. (2008) Granulocytapheresis in the treatment of patients with active ulcerative colitis. Expert Review of Gastroenterology & Hepatology 2:5, pages 639-643.
Read now

Articles from other publishers (30)

Daniel Vasile Balaban & Mariana Jinga. 2021. Crohn’s Disease Recent Advances. Crohn’s Disease Recent Advances.
Satoshi Motoya, Hiroki Tanaka, Tomoyoshi Shibuya, Taro Osada, Takayuki Yamamoto, Hitoshi Hongo, Chiemi Mizuno, Daisuke Saito, Nobuo Aoyama, Toshihisa Kobayashi, Hiroaki Ito, Satoshi Tanida, Masanori Nojima, Seiichiro Kokuma & Eiji Hosoi. (2019) Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study. BMC Gastroenterology 19:1.
Crossref
Kajsa Edfors, Dagny Ståhlberg & Charlotte Söderman. (2016) Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease. Therapeutic Apheresis and Dialysis 20:1, pages 79-85.
Crossref
H. Schulze, P. Esters & A. Dignass. (2014) Letter: leucocytapheresis as a nonpharmacologic treatment for patients with ulcerative colitis during pregnancy – authors’ reply. Alimentary Pharmacology & Therapeutics 41:2, pages 235-236.
Crossref
Takumi Fukuchi, Hiroshi Nakase, Satoshi Ubukata, Minoru Matsuura, Takuya Yoshino, Takahiko Toyonaga, Keiji Shimazu, Hideaki Koga, Hiroshi Yamashita, Dai Ito & Kiyoshi Ashida. (2014) Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn’s disease. BMC Gastroenterology 14:1.
Crossref
H H Olsen, V Muratov, K Cederlund, J Lundahl, A Eklund & J Grunewald. (2014) Therapeutic granulocyte and monocyte apheresis (GMA) for treatment refractory sarcoidosis: a pilot study of clinical effects and possible mechanisms of action. Clinical and Experimental Immunology 177:3, pages 712-719.
Crossref
Keiichi Tominaga, Masakazu Nakano, Mina Hoshino, Kazunari Kanke & Hideyuki Hiraishi. (2013) Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone. BMC Gastroenterology 13:1.
Crossref
Claudio Papi, Federica Fascì-Spurio, Francesca Rogai, Alessia Settesoldi, Giovanna Margagnoni & Vito Annese. (2013) Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors. Digestive and Liver Disease 45:12, pages 978-985.
Crossref
Wolfgang Ramlow, Grit Waitz, Gisela Sparmann, Heinrich Prophet, Peggy Bodammer & Jörg Emmrich. (2013) First Human Application of a Novel Adsorptive‐Type Cytapheresis Module in Patients With Active Ulcerative Colitis: A Pilot Study. Therapeutic Apheresis and Dialysis 17:3, pages 339-347.
Crossref
Tsutomu Mizoshita, Satoshi Tanida, Hironobu Tsukamoto, Keiji Ozeki, Takahito Katano, Masahide Ebi, Yoshinori Mori, Hiromi Kataoka, Takeshi Kamiya & Takashi Joh. (2013) Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus. ISRN Gastroenterology 2013, pages 1-7.
Crossref
Tsutomu Mizoshita, Satoshi Tanida, Shigeru Kusumoto, Keiji Ozeki, Hironobu Tsukamoto, Masahide Ebi, Yoshinori Mori, Hiromi Kataoka, Takeshi Kamiya & Takashi Joh. (2012) Adalimumab therapy following granulocyte and monocyte adsorptive apheresis in a patient with Crohn’s disease accompanied by chronic myeloid leukemia. Clinical Journal of Gastroenterology 5:4, pages 302-306.
Crossref
J. L. Cabriada, E. Domènech, N. Ibargoyen, V. Hernández, J. Clofent, D. Ginard, I. Gutiérrez-Ibarluzea & J. Hinojosa. (2011) Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry. Journal of Gastroenterology 47:4, pages 359-365.
Crossref
Keiji Ozeki, Satoshi Tanida, Takashi Mizushima, Tsutomu Mizoshita, Hironobu Tsukamoto, Yoshikazu Hirata, Kenji Murakami, Takaya Shimura, Hiromi Kataoka, Takeshi Kamiya & Takashi Joh. (2012) Combination Therapy with Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis Induced Clinical Remission in a Crohn's Disease Patient with the Loss of Response to Scheduled Adalimumab Maintenance Therapy: A Case Report. Internal Medicine 51:6, pages 595-599.
Crossref
Keiji Ozeki, Satoshi Tanida, Tsutomu Mizoshita, Hironobu Tsukamoto, Masahide Ebi, Yoshinori Mori, Hiromi Kataoka, Takeshi Kamiya & Takashi Joh. (2012) Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohns Disease. Case Reports in Gastroenterology 6:3, pages 765-771.
Crossref
Munenori Itagaki, Masayuki Saruta, Toshio Iinuma, Seiji Arihiro, Tomohiro Kato & Hisao Tajiri. (2012) Infliximab- and Immunosuppressant-Resistant Crohn’s Disease Successfully Treated with Adsorptive Granulocyte Apheresis Combined with Prednisolone. Case Reports in Gastroenterology 6:1, pages 118-123.
Crossref
José Luis Cabriada. (2012) Aféresis en enfermedad inflamatoria intestinal. ¿Una opción válida?. Gastroenterología y Hepatología 35:1, pages 22-31.
Crossref
Stefano Passalacqua, Pietro Manuel Ferraro, Giampaolo Bresci, Valeria D'Ovidio, Marco Astegiano, Mariabeatrice Principi, Roberto Testa, Renata D'Incà, Daniela Valpiani, Alessandro Armuzzi, Renato Sablich, Flaminia Cavallaro, Francesco Costa, Vincenza Di Leo, Elisabetta Colombo, Alessia Santini, Annalisa Aratari, Pierenrico Lecis, Valeria Saladino, Gabriele Riegler, Marino Marco, Francesca Calella, Chiara Ricci, Maria Luisa Guidi, Giuseppe Repaci & Michele Silla. (2011) The Italian registry of therapeutic apheresis: Granulocyte–monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study. Journal of Clinical Apheresis 26:6, pages 332-337.
Crossref
S. C. Ng, F. K. L. Chan & J. J. Y. Sung. (2011) Review article: the role of non-biological drugs in refractory inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 33:4, pages 417-427.
Crossref
Jose L. Cabriada, Nora Ibargoyen, Anaiansi Hernández, Antonio Bernal & Agustín Castiella. (2010) Sustained remission after steroids and leukocytapheresis induced response in steroid-dependent ulcerative colitis: Results at 1 year. Digestive and Liver Disease 42:6, pages 432-435.
Crossref
Brigitte Habermalz & Stefan Sauerland. (2009) Clinical Effectiveness of Selective Granulocyte, Monocyte Adsorptive Apheresis with the Adacolumn® Device in Ulcerative Colitis. Digestive Diseases and Sciences 55:5, pages 1421-1428.
Crossref
Pilar Nos & Eugeni Domènech. (2009) Tratamiento con aféresis en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 32:7, pages 509-518.
Crossref
Siew C. Ng & Michael A. Kamm. (2009) Therapeutic strategies for the management of ulcerative colitis. Inflammatory Bowel Diseases 15:6, pages 935-950.
Crossref
Subrata Ghosh, Gilaad Kaplan & Remo Panaccione. (2008) Granulocyte–monocyte apheresis for the treatment of ulcerative colitis—is this the end of the road?. Nature Clinical Practice Gastroenterology & Hepatology 6:1, pages 6-7.
Crossref
Giampaolo Bresci, Giuseppe Parisi, Alessandro Mazzoni, Fabrizio Scatena & Alfonso Capria. (2008) Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12‐month follow up. Journal of Gastroenterology and Hepatology 23:11, pages 1678-1682.
Crossref
Fridrik Thor Sigurbjörnsson & Ingvar Bjarnason. (2008) Leukocytapheresis for the treatment of IBD. Nature Clinical Practice Gastroenterology & Hepatology 5:9, pages 509-516.
Crossref
Yea Ping Lin, Carolyn H. Thibodeaux, Jeremy A. Peña, George D. Ferry & James Versalovic. (2008) Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflammatory Bowel Diseases 14:8, pages 1068-1083.
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:3, pages 284-314.
Crossref
Vladislaw Muratov, Ann-Kristin Ulfgren, Marianne Engström, Kerstin Elvin, Ola Winqvist, Robert Löfberg & Joachim Lundahl. (2008) Decreased numbers of FoxP3-positive and TLR-2-positive cells in intestinal mucosa are associated with improvement in patients with active inflammatory bowel disease following selective leukocyte apheresis. Journal of Gastroenterology 43:4, pages 277-282.
Crossref
Hiroaki Takeda, Yasukuni Suzuki, Yuji Takeda, Shoichi Nishise, Tadahisa Fukui, Shoichiro Fujishima, Tomohiko Orii, Sayaka Otake, Takeshi Sato, Koji Suzuki, Yukiko Nakamuara & Sumio Kawata. (2008) A multi center study of granulocyte and monocyte adsorption apheresis therapy for ulcerative colitis—Clinical efficacy and production of interleukin‐1 receptor antagonist. Journal of Clinical Apheresis 23:3, pages 105-110.
Crossref
Yuji Naito, Tomohisa Takagi & Toshikazu Yoshikawa. (2007) Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. Journal of Gastroenterology 42:10, pages 787-798.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.